Systemic Immunotherapy Bladder Cancer.. Get Ready! EVERYDAY UROLOGY- Full text article – UroToday
|
Systemic Immunotherapy Bladder Cancer.. Get Ready! EVERYDAY UROLOGY- Full text article
UroToday Although specific results of the study have not yet been released, a press release from Merck noted that the study's results indicated that pembrolizumab is the first immunotherapy to show improved OS compared with chemotherapy in advanced urothelial … |
